AAAAAA

   
Results: 1-14 |
Results: 14
Tandem-cycle high-dose melphalan and cisplatin with peripheral blood progenitor cell support in patients with breast cancer and other malignancies
Authors: Somlo, G Chow, W Hamasaki, V Leong, L Margolin, K Morgan, R Sniecinski, I Frankel, P Reardon, D Longmate, J Raschko, J Shibata, S O'Donnell, M Smith, E Tetef, M Forman, S Yen, Y Molina, A Doroshow, JH
Citation: G. Somlo et al., Tandem-cycle high-dose melphalan and cisplatin with peripheral blood progenitor cell support in patients with breast cancer and other malignancies, BIOL BLOOD, 7(5), 2001, pp. 284-293
Phase I trial of 96-hour continuous infusion of dexrazoxane in patients with advanced malignancies
Authors: Tetef, ML Synold, TW Chow, W Leong, L Margolin, K Morgan, R Raschko, J Shibata, S Somlo, G Yen, Y Groshen, S Johnson, K Lenz, HJ Gandara, D Doroshow, JH
Citation: Ml. Tetef et al., Phase I trial of 96-hour continuous infusion of dexrazoxane in patients with advanced malignancies, CLIN CANC R, 7(6), 2001, pp. 1569-1576
Phase II trial of high-dose intravenous doxorubicin, etoposide, and cyclophosphamide with autologous stem cell support in patients with residual or responding recurrent ovarian cancer
Authors: Morgan, RJ Doroshow, JH Leong, L Schriber, J Shibata, S Forman, S Hamasaki, V Margolin, K Somlo, G Alvarnas, J McNamara, M Longmate, J Raschko, J Chow, W Vasilev, S McGonigle, K Yen, Y
Citation: Rj. Morgan et al., Phase II trial of high-dose intravenous doxorubicin, etoposide, and cyclophosphamide with autologous stem cell support in patients with residual or responding recurrent ovarian cancer, BONE MAR TR, 28(9), 2001, pp. 859-863
High-dose paclitaxel in combination with doxorubicin, cyclophosphamide andperipheral blood progenitor cell rescue in patients with high-risk primaryand responding metastatic breast carcinoma: toxicity profile, relationshipto paclitaxel pharmacokinetics and short-term outcome
Authors: Somlo, G Doroshow, JH Synold, T Longmate, J Reardon, D Chow, W Forman, SJ Leong, LA Margolin, KA Morgan, RJ Raschko, JW Shibata, SI Tetef, ML Yen, Y Kogut, N Schriber, J Alvarnas, J
Citation: G. Somlo et al., High-dose paclitaxel in combination with doxorubicin, cyclophosphamide andperipheral blood progenitor cell rescue in patients with high-risk primaryand responding metastatic breast carcinoma: toxicity profile, relationshipto paclitaxel pharmacokinetics and short-term outcome, BR J CANC, 84(12), 2001, pp. 1591-1598
Inhibition of human cancer cell growth by inducible expression of human ribonucleotide reductase antisense cDNA
Authors: Chen, SY Zhou, BS He, FQ Yen, Y
Citation: Sy. Chen et al., Inhibition of human cancer cell growth by inducible expression of human ribonucleotide reductase antisense cDNA, ANTISENSE N, 10(2), 2000, pp. 111-116
A phase I study of carboplatin and etoposide administered in conjunction with dipyridamole, prochlorperazine and cyclosporine A
Authors: Raschko, JW Synold, TW Chow, W Coluzzi, P Hamasaki, V Leong, LA Margolin, KA Morgan, RJ Shibata, SI Somlo, G Tetef, ML Yen, Y ter Veer, A Doroshow, JH
Citation: Jw. Raschko et al., A phase I study of carboplatin and etoposide administered in conjunction with dipyridamole, prochlorperazine and cyclosporine A, CANC CHEMOT, 46(5), 2000, pp. 403-410
Comparisons of RFLP and PCR-based markers to detect polymorphism between wheat cultivars
Authors: Shah, MM Yen, Y Gill, KS Baenziger, PS
Citation: Mm. Shah et al., Comparisons of RFLP and PCR-based markers to detect polymorphism between wheat cultivars, EUPHYTICA, 114(2), 2000, pp. 135-142
Does rejection elicit hostility in rejection sensitive women?
Authors: Ayduk, O Downey, G Testa, A Yen, Y Shoda, Y
Citation: O. Ayduk et al., Does rejection elicit hostility in rejection sensitive women?, SOC COGN, 17(2), 1999, pp. 245-271
Electrochemical treatment of human KB cells in vitro
Authors: Yen, Y Li, JR Zhou, BS Rojas, F Yu, J Chou, CK
Citation: Y. Yen et al., Electrochemical treatment of human KB cells in vitro, BIOELECTROM, 20(1), 1999, pp. 34-41
Molecular mapping of loci for agronomic traits on chromosome 3A of bread wheat
Authors: Shah, MM Gill, KS Baenziger, PS Yen, Y Kaeppler, SM Ariyarathne, HM
Citation: Mm. Shah et al., Molecular mapping of loci for agronomic traits on chromosome 3A of bread wheat, CROP SCI, 39(6), 1999, pp. 1728-1732
Genetic analyses of agronomic traits controlled by wheat chromosome 3A
Authors: Shah, MM Baenziger, PS Yen, Y Gill, KS Moreno-Sevilla, B Haliloglu, K
Citation: Mm. Shah et al., Genetic analyses of agronomic traits controlled by wheat chromosome 3A, CROP SCI, 39(4), 1999, pp. 1016-1021
Overexpression of ribonucleotide reductase as a mechanism of resistance to2,2-difluorodeoxycytidine in the human KB cancer cell line
Authors: Goan, YG Zhou, BS Hu, E Mi, S Yen, Y
Citation: Yg. Goan et al., Overexpression of ribonucleotide reductase as a mechanism of resistance to2,2-difluorodeoxycytidine in the human KB cancer cell line, CANCER RES, 59(17), 1999, pp. 4204-4207
Ethnic differences in the behavior of hepatocellular carcinoma
Authors: Chin, PL Chu, DZJ Clarke, KG Odom-Maryon, T Yen, Y Wagman, LD
Citation: Pl. Chin et al., Ethnic differences in the behavior of hepatocellular carcinoma, CANCER, 85(9), 1999, pp. 1931-1936
Recombinant human thrombopoietin in combination with granulocyte colony-stimulating factor enhances mobilization of peripheral blood progenitor cells, increases peripheral blood platelet concentration, and accelerates hematopoietic recovery following high-dose chemotherapy
Authors: Somlo, G Sniecinski, I ter Veer, A Longmate, J Knutson, G Vuk-Pavlovic, S Bhatia, R Chow, W Leong, L Morgan, R Margolin, K Raschko, J Shibata, S Tetef, M Yen, Y Forman, S Jones, D Ashby, M Fyfe, G Hellmann, S Doroshow, JH
Citation: G. Somlo et al., Recombinant human thrombopoietin in combination with granulocyte colony-stimulating factor enhances mobilization of peripheral blood progenitor cells, increases peripheral blood platelet concentration, and accelerates hematopoietic recovery following high-dose chemotherapy, BLOOD, 93(9), 1999, pp. 2798-2806
Risultati: 1-14 |